Hashdex Commodities Trust (DEFI): Completion of Acquisition or Disposition of Assets

U.S. spot Bitcoin ETFs saw five straight net inflow sessions totaling about $853.5 million from Aug. 3 to Aug. 7, reversing the prior week’s $61.5 million net outflows, according to SoSoValue. BlackRock’s IBIT led with about $693 million. Total spot Bitcoin ETF net assets were $79.50B. U.S. spot Ethereum ETFs added about $244.9M over the same period.

Jazz Pharmaceuticals (JAZZ) acquired Actio Biosciences for $820M, adding epilepsy drug ABS-1230 to its pipeline. Jazz reported record Q2 revenue of $1.2B and raised 2026 guidance to $4.6B-$4.75B. The deal adds to existing debt, and ABS-1230 is in early clinical stages. Jazz's shares trade at a forward P/E of 11.03.

Xenetic Biosciences (XBIO) agreed to acquire Santersus AG in an all-stock deal, pending shareholder approval. The combined company will rebrand as Santersus Bio, Inc. and trade under SNTS. The merger focuses on neutrophil extracellular traps (NETs) for treating various diseases, with four clinical programs planned. XBIO shares fell 40.98% to $2.52 on Wednesday, according to Benzinga Pro.

Intel (INTC) and SK Hynix (SKHY) shares rose 5.5% and 3% respectively on reports of a potential U.S. chipmaking partnership. SK Hynix is considering leasing space at Intel's Ohio facility or forming a joint venture, according to Reuters. Both companies have not confirmed any finalized agreements.

Colgate-Palmolive (CL) is exploring the sale of brands like Softsoap, Irish Spring, and Speed Stick, potentially fetching over $1 billion. The company is working with Goldman Sachs (GS) on the divestiture. Personal care accounted for 17% of CL's 2025 net sales, which totaled $20.38 billion. The move is part of a broader productivity and restructuring program aimed at generating annual pre-tax savings of $200 million to $300 million by 2028.

The FCC approved foreign investment in Paramount's $110B acquisition of Warner Bros Discovery, capping foreign equity at 20% and barring voting rights. Concerns were raised by Democratic senators about Middle Eastern investors. The deal was previously blocked by a U.S. judge.